Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Blood Neoplasia|August 1, 2025
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemiaMartin Hutchings, Koorosh Korfi, Pau Montesinos, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 13, 2019
Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid LeukemiaJuan Eduardo Megías-Vericat, David Martínez-Cuadrón, Joaquín Martínez López, et al.
Blood Advances|December 15, 2021
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocolAlex Bataller, Ana Garrido, Francesca Guijarro, et al.
Cancers|May 14, 2022
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA RegistryJorge Labrador, David Martínez-Cuadrón, Adolfo de la Fuente, et al.
Cancers|April 12, 2022
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry ExperienceJorge Labrador, Miriam Saiz-Rodríguez, Dunia de Miguel, et al.
Pageof 9